Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis

Marcel Hohl1, Aditya Mojumdar2, Sarem Hailemariam3

  • 1Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.

Plos Genetics
|March 19, 2020
PubMed

Insights

Mutations in the Mre11 complex impair DNA damage signaling, specifically ATM activation, while preserving DNA repair. This separation of function suggests a mechanism by which cancer cells may evade tumor suppression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • The DNA damage response (DDR) is crucial for maintaining genomic integrity and preventing cancer.
  • The Mre11 complex and ATM kinase are key components of the DDR, implicated in tumor suppression.
  • Mutations in Mre11 complex genes are found in human cancers and cause instability syndromes.

Purpose of the Study:

  • To investigate which functions of the Mre11 complex are essential for its tumor-suppressive role.
  • To analyze cancer genomic data for mutations in MRE11 and RAD50.
  • To functionally characterize these mutations in yeast and in vitro.

Main Methods:

  • Mining of cancer genomic data from Memorial Sloan Kettering Cancer Center.
  • Modeling of 25 recurrent and conserved MRE11 and RAD50 mutations in Saccharomyces cerevisiae.
  • In vitro biochemical assays to assess DNA repair and ATM/Tel1 activation.

Main Results:

  • A significant fraction of tumor-derived MRE11 and RAD50 mutations caused a separation of function.
  • These mutations impaired Tel1/ATM activation while largely retaining DNA repair capabilities.
  • RAD50 mutations affected ATP binding and hydrolysis, crucial for Tel1/ATM activation.

Conclusions:

  • Rad50 ATPase activity is critical for ATM signaling activation.
  • Inactivation of ATM signaling by specific Mre11 complex mutations may provide a survival advantage to developing tumor cells.
  • Understanding these specific functional defects can inform cancer therapy strategies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K